Full Description
Cardiac catheterization and coronary angiography remain key tools in the management of patients with coronary heart disease. Although this is the most frequently used method of coronary revascularization, general training in cardiology rarely offers more than the opportunity to assist a more senior operator to perform angioplasty procedures.
This textbook, covering key procedures and fully revised and updated to include the latest trials, technology, and new techniques, is essential reading. The Oxford Textbook of Interventional Cardiology, 2nd edition spans the whole spectrum of interventional cardiology procedures, including a novel section on the future of interventional cardiology, and multiple new chapters covering special devices in percutaneous coronary intervention. Written by an expert team of international authors, this book offers guidance on all aspects of interventional cardiology according the European curriculum, and covers the evidence-based guidelines for a comprehensive view of the field.
Contents
Background and basics 1: Robert Henderson, Richard Varcoe: The epidemiology and pathophysiology of coronary artery disease 2: Toby Rogers, Kenneth Kent, and Augusto D. Pichard: The history of interventional cardiology 3: Peter F. Ludman: Risk assessment and analysis of outcomes 4: David H. Roberts: Vascular access: femoral versus radial 5: Gurbir Bhatia, James Nolan: Radiation and percutaneous coronary intervention 6: Rod Stables: The 'golden rules' of percutaneous coronary intervention 7: Kevin O'Gallagher, Jonathan Byrne, and Philip MacCarthy: Routine management after percutaneous coronary intervention 8: Ayman Al-Saleh and Sanjit Jolly: Trial design and interpretation: statistics in PCI Percutaneous coronary intervention-related imaging 9: David Adlam, Annette Maznyczka, and Bernard Prendergast: Angiography: indications and limitations 10: Olivier Muller, Stephane Fournier, Bernard De Bruyne: Coronary physiology in clinical practice 11: Hiromasa Otake, Yasuhiro Honda, and Peter J. Fitzgerald: The role of intravascular ultrasound in percutaneous coronary intervention 12: Ravinay Bhindi and Keith M. Channon: Optical Coherence Tomography in Percutaneous Coronary Intervention 13: A. Coenen, L.E. Swart, R.P.J. Budde, and K. Nieman: Coronary computed tomography for the interventionalist 14: Theodoros D. Karamitsos and Stefan Neubauer: Cardiovascular magnetic resonance Percutaneous coronary intervention by clinical syndrome 15: Vasim Farooq and Patrick W. Serruys: Stable coronary artery disease: medical therapy versus percutaneous coronary intervention versus surgery 16: Bashir Alaour, Michael Mahmoudi and Nick Curzen: Percutaneous coronary intervention in non-ST elevation acute coronary syndrome 17: Zulfiquar Adam and Mark A. de Belder: Primary percutaneous coronary intervention for ST elevation myocardial infarction 18: Divaka Perera and Natalia Briceno: Percutaneous coronary intervention in patients with impaired left ventricular function Percutaneous coronary intervention by lesion and patient subsets 19: Yves Louvard, Philippe Garot, Thomas Hovasse, Bernard Chevalier, and Thierry Lefèvre: Coronary bifurcation stenting: state of the art 20: Michael Mahmoudi, Nick Curzen, Christine Hughes, Bruno Farah, and Jean Fajadet: Percutaneous coronary intervention for unprotected and protected left main stem disease 21: Colm G. Hanratty, James C. Spratt, Simon J. Walsh: Chronic total occlusions 22: George Kassimis and Adrian P. Banning: Revascularisation in patients with diabetes mellitus 23: Marko Noc and Peter Radsel: Out of Hospital Arrest: Role of PCI Adjunctive drug therapies in percutaneous coronary intervention 24: Vikram Khanna, Tony Gershlick and Nick Curzen: Current status of oralantiplatelet therapies 25: Tim Lockie: Current status of GP IIb/IIIa inhibitors 26: Stefanie Schüpke, Steffen Massberg, and Adnan Kastrati: The role of bivalirudin in percutaneous coronary intervention 27: Simon J. Corbett and Nick Curzen: Optimal medical therapy in percutaneous coronary intervention patients: statins and ACE inhibitors as disease-modifying agents 28: Mikhail S. Dzeshka, Richard A. Brown, and Gregory Y.H. Lip: New Oral Anti-Coagulants (NOACs) and other Adjunctive Therapies Complications of percutaneous coronary intervention 29: Peter A. McCullough: Contrast-induced acute kidney injury 30: Jaya Chandrasekhar, Adriano Caixeta, Philippe Généreux, George Dangas, and Roxana Mehran: In-stent restenosis in the drug-eluting stent era 31: Nikesh Malik, Amerjeet Banning, and Tony Gershlick: Stent thrombosis 32: Adam de Belder: Stent loss and retrieval 33: Mark Gunning and Chee Wah Khoo: Coronary artery perforation Special devices in percutaneous coronary intervention 34: Adam de Belder, Martyn Thomas, and Emanuele Barbato: Rotational atherectomy 35: Peter O'Kane and Simon Redwood: Laser 36: Giovanni Luigi De Maria and Adrian P. Banning: Saphenous Vein Graft PCI, Distal Protection and no-reflow 37: Adam J. Brown and Nick E. J. West: Bioresorbable Vascular Scaffolds 38: Corrado Tamburino, Claudia Ina Tamburino and Sebastiano Immè: Access Sites and the TAVI Procedure 39: Mohamed Abdel-Wahab and John Jose: Selection of TAVI Prostheses 40: Muhammed Zeeshan Khawaja and Simon Redwood: Co-existent Coronary Artery Disease in Patients Undergoing TAVI: When and When Not to Treat 41: Michael Bellamy and Christopher Baker: Transcatheter Mitral Valve Repair 42: Ricardo Boix Garibo, Mohsin Uzzaman, Michael Ghosh-Dastidar, and Vinayak Bapat: Transcatheter Mitral Valve Replacement Other Non-coronary percutaneous interventions 43: Patrick A. Calvert, Bushra S. Rana, Roland Hilling-Smith, and David Hildick-Smith: Percutaneous device closure of atrial septal defect and patent foramen ovale 44: Alec Vahanian, Dominique Himbert, Eric Brochet, Grégory Ducrocq, and Bernard Iung: Mitral balloon valvuloplasty 45: Charles Knight, Saidi Mohiddin, and Constantinos O'Mahony: Alcohol septal ablation for obstructive hypertrophic cardiomyopathy 46: Iqbal Malik and Mohamed Hamady: Carotid artery stenting 47: Tim Betts: Left Atrial Appendage Occlusion The Future 48: Kenneth Chan, Manish Saxena, and Melvin D. Lobo: Novel Therapies for Hypertension 49: Giora Weisz: Robotic PCI 50: Fizzah Choudry and Anthony Mathur: Stem Cell Therapy and Delivery
